Ablation therapy of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and primary electrical diseases: new insights in invasive treatment options in severely symptomatic patients

Onderzoeksoutput: Article

Samenvatting

Achieving the goal management of some arrhythmic syndromes can be challenging; medical treatment for inappropriate sinus tachycardia (IST) and postural orthostatic tachycardia syndrome (POTS) may be ineffective, necessitating multidisciplinary team treatment. Implantable defibrillator devices (ICDs), along with anti-arrhythmic drugs (AADs), remain the first-line treatment for primary electrical diseases that pose a risk of sudden cardiac death (SCD). Ablation of the arrhythmogenic substrate is not always suggested in patients with these pathologies, but it may be a valuable support for reducing arrhythmic burden, improving quality of life, and treating pathologies that are resistant to pharmacological treatment; however, this option is not often considered due to the potential risks associated with an invasive approach. Minimally invasive hybrid ablation in these syndromes, such as a hybrid thoracoscopic approach and the use of non-invasive mapping systems, reduces post-surgery complications and ensures the best possible outcome for the patient.

Originele taal-2English
Pagina's (van-tot)323-329
Aantal pagina's7
TijdschriftHerzschrittmachertherapie & Elektrophysiologie
Volume32
Nummer van het tijdschrift3
DOI's
StatusPublished - sep 2021

Bibliografische nota

© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Vingerafdruk

Duik in de onderzoeksthema's van 'Ablation therapy of postural orthostatic tachycardia syndrome, inappropriate sinus tachycardia and primary electrical diseases: new insights in invasive treatment options in severely symptomatic patients'. Samen vormen ze een unieke vingerafdruk.

Citeer dit